Last 48 quarters of trend data · Healthcare · Contract Research & Manufacturing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.93 | — | — | — | 18.87 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.75 | 0.92 | 1.71 | 1.39 | 1.09 | 1.97 | 2.18 | 1.48 | 1.67 | 1.75 | 2.34 | 3.33 | 5.15 | 4.45 | 5.87 | 4.33 | 2.97 | 4.47 | 6.15 | 8.12 | 10.96 |
| — | -53.2% | -21.7% | -6.0% | -34.6% | +12.4% | -6.8% | -55.4% | -67.7% | -60.7% | -60.2% | -23.2% | +73.6% | -0.4% | -4.5% | -46.7% | -72.9% | -63.5% | -54.7% | -28.7% | +11.2% | |
| P/B Ratio | 0.66 | 0.95 | 1.50 | 1.27 | 1.35 | 1.61 | 1.50 | 1.20 | 1.55 | 1.20 | 1.57 | 2.32 | 3.71 | 2.89 | 3.12 | 3.11 | 2.41 | 2.58 | 3.17 | 4.08 | 5.95 |
| — | -41.2% | -0.5% | +5.3% | -13.1% | +34.6% | -4.3% | -48.2% | -58.2% | -58.6% | -49.7% | -25.4% | +53.9% | +12.0% | -1.7% | -23.7% | -59.5% | -62.0% | -57.2% | -37.2% | -4.8% | |
| P/FCF | — | — | — | — | 5.88 | — | 138.34 | — | 7.51 | 22.69 | — | — | — | — | — | — | — | — | 7.64 | 64.59 | 49.32 |
| — | — | — | — | -21.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | -99.0% | — | — | |
| EV / EBITDA | — | — | — | — | 5.87 | — | — | — | 32.95 | — | — | — | 90.70 | 73.46 | — | 39.07 | 13.87 | — | — | — | — |
| — | — | — | — | -82.2% | — | — | — | -63.7% | — | — | — | +553.7% | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | 8.54 | — | — | — | — | — | — | — | — | — | — | 88.22 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 8.3% | 12.0% | -1.1% | -1.0% | 31.0% | -0.0% | 5.0% | 13.6% | 20.8% | 9.9% | 8.6% | 16.7% | 18.7% | 19.3% | 27.2% | 24.9% | 34.3% | 16.3% | 17.9% | 19.6% | 27.8% |
| — | +31852.4% | -121.9% | -107.4% | +48.7% | -100.4% | -41.9% | -18.2% | +11.4% | -48.7% | -68.2% | -33.2% | -45.4% | +17.9% | +51.6% | +27.1% | +23.1% | -39.5% | -3.2% | -14.9% | +7.0% | |
| Operating Margin | -17.9% | -16.4% | -35.6% | -35.4% | 9.6% | -27.2% | -16.2% | -10.0% | 3.1% | -14.3% | -57.4% | -8.7% | -5.7% | -6.2% | -21.3% | 5.9% | 15.7% | -7.8% | -2.2% | 0.3% | 8.0% |
| — | +39.5% | -119.7% | -253.7% | +212.7% | -89.5% | +71.8% | -14.7% | +153.5% | -130.8% | -169.5% | -248.8% | -136.6% | +20.2% | -873.4% | +1984.0% | +96.0% | -170.0% | -296.9% | -94.5% | -15.2% | |
| Net Margin | -13.1% | -16.2% | -32.5% | -77.8% | 5.8% | -26.3% | -25.4% | -15.8% | -18.5% | -21.4% | -52.1% | -9.9% | -8.0% | -19.8% | -8.8% | -6.5% | -11.3% | -27.2% | -16.2% | -44.5% | -16.8% |
| — | +38.3% | -28.0% | -393.0% | +131.3% | -22.6% | +51.3% | -59.4% | -130.4% | -8.0% | -494.5% | -52.2% | +29.1% | +27.0% | +46.0% | +85.4% | +32.8% | -132.3% | -137.4% | -212.3% | -5967.1% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -11.3% | -4.1% | -6.9% | -16.4% | 1.8% | -4.8% | -4.4% | -3.3% | -4.0% | -3.7% | -8.3% | -1.8% | -1.4% | -3.1% | -1.2% | -1.2% | -2.3% | -3.7% | -2.1% | -5.5% | -2.5% |
| — | +14.9% | -58.0% | -402.5% | +144.7% | -31.3% | +47.2% | -82.5% | -189.8% | -17.0% | -588.7% | -52.6% | +39.1% | +16.0% | +42.8% | +78.5% | +8.6% | -130.0% | -134.2% | -194.0% | -4299.3% | |
| ROA | -5.4% | -1.7% | -2.9% | -7.2% | 0.8% | -2.2% | -2.1% | -1.6% | -2.0% | -1.8% | -4.2% | -0.9% | -0.7% | -1.6% | -0.8% | -0.8% | -1.2% | -2.0% | -1.2% | -3.3% | -1.5% |
| — | +21.5% | -43.3% | -360.7% | +141.3% | -21.8% | +50.9% | -76.5% | -184.1% | -14.2% | -419.4% | -10.5% | +42.8% | +22.4% | +33.8% | +75.6% | +17.3% | -130.3% | -138.4% | -216.2% | -5583.6% | |
| ROIC | -10.5% | -2.6% | -5.2% | -5.5% | 1.8% | -2.9% | -1.7% | -1.3% | 0.4% | -1.5% | -5.7% | -1.0% | -0.6% | -0.7% | -1.7% | 0.6% | 2.2% | -0.9% | -0.2% | 0.0% | 0.9% |
| — | +8.5% | -202.7% | -317.0% | +342.4% | -94.6% | +69.6% | -36.4% | +165.7% | -114.5% | -240.8% | -264.2% | -128.4% | +20.9% | -570.8% | +1896.3% | +153.3% | -181.8% | -340.6% | -94.1% | -25.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.55 | 0.65 | 0.71 | 0.55 | 0.55 | 0.61 | 0.55 | 0.52 | 0.47 | 0.49 | 0.47 | 0.57 | 0.73 | 0.52 | 0.45 | — | 0.43 | 0.40 | 0.38 | 0.40 | 0.37 |
| — | +7.4% | +30.9% | +5.5% | +18.2% | +24.8% | +16.7% | -7.5% | -36.0% | -6.0% | +2.9% | — | +70.6% | +28.8% | +20.1% | — | +14.6% | -20.6% | -37.0% | -39.3% | -45.2% | |
| Debt / EBITDA | — | — | — | — | 9.34 | — | — | — | 36.25 | — | — | — | 66.39 | 51.06 | — | — | 9.48 | — | — | — | — |
| — | — | — | — | -74.2% | — | — | — | -45.4% | — | — | — | +600.1% | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.07 | 2.32 | 2.33 | 1.68 | 2.07 | 2.12 | 1.58 | 2.03 | 1.98 | 2.09 | 1.83 | 1.86 | 1.94 | 2.16 | 2.10 | — | 3.18 | 3.22 | 3.57 | 3.13 | 3.39 |
| — | +9.6% | +47.9% | -17.2% | +4.7% | +1.2% | -14.0% | +8.8% | +1.8% | -3.3% | -12.8% | — | -38.9% | -32.7% | -41.1% | — | -6.3% | +29.9% | +38.9% | +10.1% | +7.3% | |
| Quick Ratio | 1.99 | 2.19 | 2.21 | 1.60 | 1.99 | 2.03 | 1.49 | 1.93 | 1.89 | 1.99 | 1.73 | 1.79 | 1.88 | 2.09 | 2.04 | — | 3.09 | 3.12 | 3.48 | 3.05 | 3.31 |
| — | +7.6% | +48.6% | -17.2% | +5.5% | +2.5% | -14.0% | +7.9% | +0.6% | -5.0% | -15.1% | — | -39.3% | -33.1% | -41.5% | — | -6.7% | +30.9% | +39.2% | +9.8% | +7.0% | |
| Interest Coverage | -7.89 | -4.64 | -17.19 | -46.30 | 8.84 | -18.82 | -4.77 | -11.40 | -2.59 | -24.12 | -13.18 | -6.81 | -6.55 | -3.46 | -12.27 | 5.01 | -4.62 | -12.01 | -5.64 | -15.56 | -4.92 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EVO stock.
Evotec SE's current P/E is -2.9x. The average P/E over the last 1 quarters is 18.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Evotec SE's current operating margin is -17.9%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Evotec SE's business trajectory between earnings reports.